Follow the Jagsonpal Pharmaceuticals Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Jagsonpal Pharmaceuticals Limited has published 3 reports. Market capitalisation: €15.2bn. The latest transaction was disclosed on 27 June 2022 (Sale). Among the most active insiders: ARESKO PREGRESSIVE PVT. LTD. As partner J & P Investments Partnership. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Jagsonpal Pharmaceuticals Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of pharmaceutical products. It is listed on the Bombay Stock Exchange.